Licensing Agreements
EpiCept licenses patent for Bupivacaine in back pain to DURECT
Published in Law and Health Weekly, January 27th, 2007
Under the terms of the agreement, EpiCept will receive a $1.0 million upfront payment and up to an additional $9.0 million in milestone payments as well as certain royalty payments on future product sales.
"The signing of this license agreement directly supports our strategy to broaden the application of EpiCept's patent estate in managing back pain...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law and Health Weekly
More Articles from Law and Health Weekly
- Adverse Drug Reactions
Reports from College of Medicine, Division of Gastroenterology add new data to research in adverse drug reactions - Alzheimer Disease
Alzheimer's Association reports patients can retain independence longer with technology - Asbestosis
Studies conducted at Catholic Medical Center on asbestosis recently published - Bullying
Researchers from Indiana University discuss findings in bullying in children - Business & Finance
IRIDEX now current on its U.S. Securities & Exchange Commission filings - Business Update
Barr confirms generic Thalomid capsule application to the U.S. FDA - More from this issue of Law and Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
